Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alector Inc (NQ: ALEC ) 4.810 -0.120 (-2.43%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 331,652 Open 5.040 Bid (Size) 4.810 (10) Ask (Size) 6.050 (8) Prev. Close 4.930 Today's Range 4.810 - 5.052 52wk Range 3.660 - 8.900 Shares Outstanding 83,351,778 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024) September 19, 2024 From Alector, Inc. Via GlobeNewswire Alector to Participate in Upcoming Healthcare Conferences August 29, 2024 From Alector, Inc. Via GlobeNewswire Performance YTD -39.80% -39.80% 1 Month -9.07% -9.07% 3 Month +5.95% +5.95% 6 Month -20.10% -20.10% 1 Year -27.12% -27.12% More News Read More Alector Reports Second Quarter 2024 Financial Results and Provides Business Update August 07, 2024 From Alector, Inc. Via GlobeNewswire Alector to Host Mid-Year Earnings Conference Call July 31, 2024 From Alector, Inc. Via GlobeNewswire Recap: Alector Q4 Earnings February 27, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga Earnings Outlook For Alector February 26, 2024 Via Benzinga Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®) July 28, 2024 From Alector, Inc. Via GlobeNewswire Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024 July 23, 2024 From Alector, Inc. Via GlobeNewswire Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference June 20, 2024 From Alector, Inc. Via GlobeNewswire Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Session June 10, 2024 Via Benzinga Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform June 10, 2024 From Alector, Inc. Via GlobeNewswire Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 03, 2024 From Alector, Inc. Via GlobeNewswire Alector to Participate in Upcoming Healthcare Conferences May 09, 2024 From Alector, Inc. Via GlobeNewswire ALEC Stock Earnings: Alector Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Alector Reports First Quarter 2024 Financial Results and Provides Business Update May 08, 2024 From Alector, Inc. Via GlobeNewswire Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback March 28, 2024 Via Investor's Business Daily Exposures Product Safety Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 06, 2024 Via InvestorPlace Alector to Participate in Upcoming Healthcare Conferences February 28, 2024 From Alector, Inc. Via GlobeNewswire Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update February 27, 2024 From Alector, Inc. Via GlobeNewswire Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call February 20, 2024 From Alector, Inc. Via GlobeNewswire Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease February 08, 2024 From Alector, Inc. Via GlobeNewswire FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) February 07, 2024 From Alector, Inc. Via GlobeNewswire Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs January 23, 2024 Via InvestorPlace Alector Announces Closing of Public Offering January 19, 2024 From Alector, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.